Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade

Affiliations

• ¹ State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
• ² Lung Cancer Research Centre and State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China.
• ³ Shanxi Bethune Hospital Affiliated with Shanxi Academy of Medical Sciences, Taiyuan, China.
• ⁴ Lung Cancer Research Centre and State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, China. zhangli@sysucc.org.cn.
• ⁵ State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. wangyanyifu@163.com.
• ⁶ State Key Laboratory of Molecular Oncology and Department of Internal Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. gbzhou@cicams.ac.cn.